The Enterprise Value as of December 2025 (TTM) for Santhera Pharmaceuticals Holding AG (SPHDF) is 217.04M

According to Santhera Pharmaceuticals Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 217.04M. This represents a change of 50.99% compared to the average of 143.74M of the last 4 quarters.

Santhera Pharmaceuticals Holding AG (SPHDF) Historical Enterprise Value (quarterly & annually)

How has SPHDF Enterprise Value performed in the past?

The mean historical Enterprise Value of Santhera Pharmaceuticals Holding AG over the last ten years is 169.18M. The current 217.04M Enterprise Value has changed 12.73% with respect to the historical average. Over the past ten years (40 quarters), SPHDF's Enterprise Value was at its highest in in the December 2015 quarter at 460.96M. The Enterprise Value was at its lowest in in the December 2010 quarter at -9938504.00.

Santhera Pharmaceuticals Holding AG (SPHDF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Santhera Pharmaceuticals Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Santhera Pharmaceuticals Holding AG (SPHDF) Average Enterprise Value

How has SPHDF Enterprise Value performed in the past?

The current Enterprise Value of Santhera Pharmaceuticals Holding AG (SPHDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Santhera Pharmaceuticals Holding AG (SPHDF) Enterprise Value vs. Peers

How is SPHDF’s Enterprise Value compared to its peers?

Santhera Pharmaceuticals Holding AG’s Enterprise Value is less than Genfit S.A. (260.57M), less than JW (Cayman) Therapeutics Co. Ltd (886.52M), less than Silence Therapeutics plc (246.54M), greater than Molecular Partners AG (46.83M), greater than Brii Biosciences Limited (-453427127.87), greater than Botanix Pharmaceuticals Limited (172.49M), greater than Innate Pharma S.A. (128.18M), greater than NDT Pharmaceuticals Inc. (158.40M), less than Oryzon Genomics S.A. (235.74M), less than NervGen Pharma Corp. (438.78M),

Build a custom stock screener for Santhera Pharmaceuticals Holding AG (SPHDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santhera Pharmaceuticals Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santhera Pharmaceuticals Holding AG (SPHDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santhera Pharmaceuticals Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.